RxDoctor Payments Data

R Anderson, MD

Interventional Cardiology · Gainesville, FLNPI 1669425047

Payments from drug & device makers

What this record shows

Medtronic accounts for 69.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $6,501 and has fallen 69.8% since, to $1,965 in 2025.

$13,275in general payments, 2019–2025

Across 201 payments — averaging $66.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Abbott$2K
  • Boston Scientific$581
  • Teleflex LLC$269
  • Abiomed$208
  • ZOLL Circulation Inc$167
  • plus $472 from 8 others
$224,593in research payments, 2019–2025

Across 29 payments — averaging $7744.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$131K
  • Medtronic$94K

What the payments were for

  • Travel & lodging$7,40456%
  • Food & beverage$5,87144%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,275 in reported general payments places this provider in the 65th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$322,695
Medicare patients
2,463
Services billed
5,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$51,886
JardianceEmpagliflozin14$9,425
Metoprolol Succinate64$973
Isosorbide Mononitrate ErIsosorbide Mononitrate27$614
Atorvastatin Calcium47$412
ClopidogrelClopidogrel Bisulfate12$258
Lisinopril35$189
Rosuvastatin Calcium14$180
Spironolactone22$167
Losartan Potassium14$111
Metoprolol Tartrate20$91
Carvedilol16$57
Furosemide11$26

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →